Back of the napkin scribble on what azer-cel could possibly be worth if it was to be brought by BP.
The current DLBCL market is projected to be worth $2.5B USD at peak sales per year, hypothetically if IMU could project that they could take 50% market share then we are looking in the neighborhood of $1.25B USD per year.. If we go by the notion that BP is willing to pay around 4 times peak sales that puts us at about a $5B USD valuation or $7.5B AUD. This doesn't take into account that we could ask a premium for our product as we have the ability to manufacture and deliver to BP. Rough numbers that you could be looking at is maybe $8B AUD, thus adding another $1 to the share price in 1-2 years time.
I would suggest that this is a pretty good investment considering its only targeting blood cancer and we still have multiple products targeting solid tumors.
I'd take an additional dollar on the SP any day of the week
I could be way off so open to other predictions
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene Receives Positive Feedback From FDA
Ann: Imugene Receives Positive Feedback From FDA, page-73
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
45 | 5443565 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 2171910 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 4613688 | 0.048 |
36 | 4066646 | 0.047 |
46 | 3070983 | 0.046 |
60 | 6170008 | 0.045 |
11 | 1951364 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 1200533 | 2 |
0.050 | 4130537 | 15 |
0.051 | 6179811 | 13 |
0.052 | 2579418 | 10 |
0.053 | 1158504 | 8 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |